OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Contract fill/finish services gear up for pandemic vaccine demands.
The COVID-19 pandemic has created a rise in demand for contract services.
Cellular and gene therapy fields are currently on track for a serious capacity crunch.
October 29, 2020
Catalent has signed an agreement with Bone Therapeutics for the acquisition of Skeletal Cell Therapy Support SA (SCTS).
3P Biopharmaceuticals, and Oxford University spin-out, SpyBiotech, have signed a vaccine contract manufacturing agreement.
October 21, 2020
Vetter has moved into new headquarters located in Ravensburg, Germany, and plans to continue its long-term investment for corporate development.
October 14, 2020
Cambrex has completed the expansion of its solid form screening and crystallization process development facility in Edinburgh, Scotland.
October 07, 2020
Following a recent expansion at its Cambridge, MA, facility, the company now houses a new suite of cellular analysis platforms that enhance its exploratory capabilities into oncology, neuroscience, and rare diseases.
The company’s new CytoML Experiment Suite fully automates each stage of the flow cytometry data lifecycle, allowing for clearer data visualization and analysis.
October 03, 2020
More complex and challenging compounds require a more tailored approach to formulation strategies.
Industry experts discuss challenges and best practices for scaling up manufacturing under a short deadline.
October 02, 2020
Facility and equipment design are important, but the team and its experience matter most.
Cellular and gene therapy fields are currently on track for, if not already experiencing, a serious capacity crunch.
September 24, 2020
The radiopharmaceutical CDMO is building a new cGMP facility in Springfield, NJ.
September 23, 2020
CMDO Piramal Pharma Solutions held a grand opening at a facility they acquired in Sellersville, PA.
September 09, 2020
The investment at its Madison, WI, facility will expand MilliporeSigma’s capacity for high-potent active pharmaceutical ingredient production and allow for continuous flow manufacturing of ADCs.
The company is investing $130 million to add Phase III through commercial-scale manufacturing suites to its gene therapy campus in Harmans, MD.
August 28, 2020
Thermo Fisher Scientific is increasing access to cry-electron microscopy with the help of contract research organizations.
August 24, 2020
Catalent will manufacture drug substance for AZD1222 at its Harmans, MD facility.
August 21, 2020
CDMO Avid Bioservices will provide development and drug substance manufacturing for Oragenics’ novel COVID-19 vaccine candidate, Terra CoV-2.
August 14, 2020
Experts at Hovione describe progress being made in understanding how to optimize continuous processes for oral solid-dosage drug products.
August 13, 2020
The company has made several moves in recent weeks to expand manufacturing capacity and cell line services.
August 03, 2020
The investment will allow for the expansion of analytical R&D efforts and will support the company’s reference materials business.